top of page
HOME
About ABAHE
Follow the rare ones!
Rare Disease Day
ABOUT ATAXIAS
Ataxia map
Common symptoms
Is there a cure for ataxia?
Diagnosis
Support Groups
ATAXIA FACT SHEETS
SCA1 Fact Sheet
SCA2 Fact Sheet
SCA3 Fact Sheet
SCA5 Fact Sheet
SCA6 Fact Sheet
SCA7 Fact Sheet
SCA8 Fact Sheet
SCA10 Fact Sheet
SCA17 Fact Sheet
SCA27B Fact Sheet
DRPLA Fact Sheet
Episodic Ataxia Fact Sheet
Friedreich Ataxia Fact Sheet
CANVAS Fact Sheet
AOA Fact Sheet
AVED Fact Sheet
AT Fact Sheet
SCAR9 Fact Sheet
RESEARCH
Interview
References
BLOG
TREATMENT
Medications
Frequently asked questions
Ask the Expert
Caregivers
Neurological physiotherapy
Speech therapy
Occupational therapy
ADVOCACY
VIDEOS
Videos ataxia.info
Videos NAF
MORE...
Team
Contact form
Use tab to navigate through the menu items.
ataxia.info blog
News related to research, medications, events, laws, and other topics of interest to people with ataxia.
Use the search field (magnifying glass) to locate articles.
Event at the National Academy of Medicine: Meeting with ITEC (Parliamentary Front on Rare Diseases)
Event at the National Academy of Medicine: Meeting with ITEC (Parliamentary Front on Rare Diseases) in August 2025
Márcio
Aug 24
1 min read
Public Hearing in the Chamber on Friedreich's Ataxia
Public Hearing on Friedreich's ataxia on August 19, 2025.
Márcio
Aug 20
1 min read
Biogen Initiates Phase 3 Study of Omaveloxolone in Children with Friedreich's Ataxia
Biogen initiates Phase 3 study with Omaveloxolone in children with Friedreich's ataxia.
Márcio
Jul 21
1 min read
68th Meeting of the State Committee for the Defense of the Human Rights of People with Rare Diseases
Meeting of the State Committee for the Defense of Human Rights of People with Rare Diseases
Márcio
May 22
1 min read
@ataxia_info present at the III Congress of Rare Diseases
@ataxia_info and @renata_ataxia present at the 3rd Congress on Rare Diseases
Márcio
May 21
1 min read
ANVISA approves Skyclarys for the treatment of Friedreich's ataxia
ANVISA approves Skyclarys for Friedreich's ataxia
Márcio
Apr 12
1 min read
bottom of page